3u2d
From Proteopedia
(Difference between revisions)
m (Protected "3u2d" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | + | [[Image:3u2d.png|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3u2d", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3u2d| PDB=3u2d | SCENE= }} | ||
- | + | ===S. aureus GyrB ATPase domain in complex with small molecule inhibitor=== | |
- | + | ||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_22183167}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 22183167 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_22183167}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | [[3u2d]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3U2D OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:022183167</ref><references group="xtra"/> | ||
+ | [[Category: Staphylococcus aureus]] | ||
+ | [[Category: Boriack-Sjodin, P A.]] | ||
+ | [[Category: Eakin, A E.]] | ||
+ | [[Category: Prince, D B.]] | ||
+ | [[Category: Sherer, B A.]] | ||
+ | [[Category: Antimicrobial]] | ||
+ | [[Category: Atp-binding]] | ||
+ | [[Category: Isomerase-isomerase inhibitor complex]] | ||
+ | [[Category: Protein-inhibitor complex]] | ||
+ | [[Category: Structure-based drug design]] |
Revision as of 06:16, 11 January 2012
S. aureus GyrB ATPase domain in complex with small molecule inhibitor
Template:ABSTRACT PUBMED 22183167
About this Structure
3u2d is a 2 chain structure with sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
Reference
- Eakin AE, Green O, Hales N, Walkup GK, Bist S, Singh A, Mullen G, Bryant J, Embrey K, Gao N, Breeze A, Timms D, Andrews B, Uria-Nickelsen M, Demeritt J, Loch JT 3rd, Hull K, Blodgett A, Illingworth RN, Prince B, Boriack-Sjodin PA, Hauck S, Macpherson LJ, Ni H, Sherer B. Pyrrolamide DNA Gyrase Inhibitors: Fragment-based NMR Screening to Antibacterial Agents. Antimicrob Agents Chemother. 2011 Dec 19. PMID:22183167 doi:10.1128/AAC.05485-11